Blueshift Asset Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,766
Closed -$206K 495
2025
Q1
$206K Buy
+4,766
New +$241K 0.08% 336
2023
Q4
Sell
-5,887
Closed -$402K 295
2023
Q3
$402K Buy
+5,887
New +$499K 0.24% 123
2022
Q4
Sell
-21,586
Closed -$701K 438
2022
Q3
$701K Buy
21,586
+2,727
+14% +$112K 0.15% 195
2022
Q2
$743K Sell
18,859
-24,095
-56% -$1.29M 0.12% 245
2022
Q1
$3M Buy
+42,954
New +$3.14M 0.27% 95
2021
Q4
Sell
-13,873
Closed -$1.32M 964
2021
Q3
$1.32M Buy
+13,873
New +$1.46M 0.07% 330
2020
Q1
Sell
-8,052
Closed -$745K 351
2019
Q4
$745K Buy
8,052
+1,328
+20% +$117K 0.08% 338
2019
Q3
$608K Buy
+6,724
New +$766K 0.09% 313

Other funds holding EXAS

Blueshift Asset Management's EXAS Position: Q2 2025 in Review

Blueshift Asset Management sold out of Exact Sciences (EXAS) in Q2 2025, closing a stake of 4,766 shares — an estimated $206K sold.

Blueshift Asset Management first reported a position in EXAS in Q3 2019 and held it in 8 quarters. The position peaked at $3M in Q1 2022. 558 funds tracked by Wall St. Rank hold EXAS as of Q2 2025.

  • Blueshift Asset Management reported no remaining Exact Sciences position as of Q2 2025 after selling out during the quarter.
  • Blueshift Asset Management sold 4,766 Exact Sciences shares in Q2 2025, an estimated $206K.
  • Blueshift Asset Management first reported a position in Exact Sciences in Q3 2019 and held it in 8 quarters.
  • Blueshift Asset Management's Exact Sciences position peaked at $3M in Q1 2022.
  • 558 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2025.

Based on Blueshift Asset Management's 13F filing for Q2 2025, filed 13 Aug 2025.